Search
Search Results
-
Development and validation of a respiratory syncytial virus multiplex immunoassay
PurposeRespiratory syncytial virus (RSV) is one of the leading causes of severe respiratory disease in infants and adults. While vaccines and...
-
A man with diarrhea
Respiratory syncytial virus (RSV) primarily affects infants and children and can manifest as upper airway dysfunction. Patients at the highest risk...
-
Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis
ObjectiveA notable research gap exists in the systematic review and meta-analysis concerning the efficacy, immunogenicity, and safety of the...
-
Impact of universal immunization program with monoclonal antibody nirsevimab on reducing the burden of serious bronchiolitis that need pediatric intensive care
RSV bronchiolitis remains the leading cause of hospitalization in children under 1 year of age. It is estimated that 2–6% of cases will be...
-
-
Role of the cAMP-PKA-NF-κB pathway in Mucin1 over-expression in A549 cells during Respiratory syncytial virus infection
Respiratory syncytial virus (RSV) is the most common pathogen associated with acute lower respiratory tract infections in infants and young children...
-
The risk of hospitalisation from RSV is not increased by co-infection in children under 24-months-of-age
The recent pandemic prompted renewed interest in paediatric respiratory infections, including whether co-infections – particularly with RSV – have an...
-
Diagnostic value of routine blood tests in differentiating between SARS-CoV-2, influenza A, and RSV infections in hospitalized children: a retrospective study
BackgroundThe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), influenza A, and respiratory syncytial virus (RSV) infections have...
-
The global burden of lower respiratory infections attributable to respiratory syncytial virus in 204 countries and territories, 1990–2019: findings from the Global Burden of Disease Study 2019
AimsThe purpose of this study is to investigate the global epidemiological characteristics of lower respiratory infections (LRI) burden attributable...
-
Impact of COVID‑19 pandemic restrictions and subsequent relaxation on the prevalence of respiratory virus hospitalizations in children
BackgroundThe COVID-19 pandemic and the consequently adopted worldwide control measures have resulted in global changes in the epidemiology and...
-
Transient increased risk of influenza infection following RSV infection in South Africa: findings from the PHIRST study, South Africa, 2016–2018
BackgroundLarge-scale prevention of respiratory syncytial virus (RSV) infection may have ecological consequences for co-circulating pathogens,...
-
Network pharmacology combined with metabolomics to explore the mechanism for Lonicerae Japonicae flos against respiratory syncytial virus
BackgroundRespiratory Syncytial Virus (RSV) stands out as a primary contributor to lower respiratory tract infections and hospitalizations,...
-
Respiratory syncytial virus: can we still believe that after pandemic bronchiolitis is not a critical issue for public health?
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection among infants and young children, resulting in annual...
-
-
Evolving Epidemiology of Pediatric Respiratory Syncytial Virus (RSV) Cases Around COVID-19 Pandemic: Impact and Clinical Insights, Retrospective Cohort Study
BackgroundThe burden of respiratory syncytial virus (RSV) in high-risk pediatric patients remains unclear. Therefore, this study aims to characterize...
-
Respiratory Syncytial Virus Prefusion F Subunit Vaccine: First Approval of a Maternal Vaccine to Protect Infants
Pfizer is develo** a bivalent respiratory syncytial virus (RSV) prefusion F subunit vaccine (RSVpreF; ABRYSVO™) for preventing RSV illness in...
-
Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps
Respiratory syncytial virus (RSV) is a significant global health concern and major cause of hospitalization, particularly among infants and older...
-
Clinical and economic burden of respiratory syncytial virus in children aged 0–5 years in Italy
BackgroundRespiratory syncytial virus (RSV) is among the leading causes of hospitalization due to lower respiratory tract infections (LRTIs) in...
-
Clinical features and outcomes of influenza and RSV coinfections: a report from Canadian immunization research network serious outcomes surveillance network
BackgroundInfluenza and RSV coinfections are not commonly seen but are concerning as they can lead to serious illness and adverse clinical outcomes...
-
Rückschlagventile
Patients benefit from the use of check valves when drugs with a particularly short half-life (e.g., catecholamines) are continually administered...
